CN Patent

CN101175484A — 可分散波生坦片剂

Assigned to Actelion Pharmaceuticals Ltd · Expires 2008-05-07 · 18y expired

What this patent protects

本发明涉及可分散片剂，包括化合物4－叔丁基－N－[6－(2－羟基－乙氧基)－5－(2－甲氧基－苯氧基)－2－(嘧啶－2－基)－嘧啶－4－基]－苯磺酰胺。

USPTO Abstract

本发明涉及可分散片剂，包括化合物4－叔丁基－N－[6－(2－羟基－乙氧基)－5－(2－甲氧基－苯氧基)－2－(嘧啶－2－基)－嘧啶－4－基]－苯磺酰胺。

Drugs covered by this patent

Tracleer (BOSENTAN) · AstraZeneca

Patent Metadata

Patent number: CN101175484A
Jurisdiction: CN
Classification: —
Expires: 2008-05-07
Drug substance claim: No
Drug product claim: No
Assignee: Actelion Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.